At this time, patents prevent any company from making generic Edarbyclor (azilsartan/chlorthalidone) in the United States. The first patent is scheduled to expire in June 2012, which is the earliest estimated date that a generic version could become available. However, new patents for specific uses or lawsuits may delay the manufacturing of a generic version of this medication.
Can I Buy Generic Edarbyclor?Edarbyclor™ (azilsartan/chlorthalidone) is a prescription medication used to treat high blood pressure, known medically as hypertension. It is a combination product, containing two different high blood pressure medications. Azilsartan (Edarbi®) is an angiotensin II receptor blocker; chlorthalidone (Thalitone®) is a diuretic.
Edarbyclor is made by Takeda Pharmaceuticals America, Inc. It is currently under the protection of patents that prevent any generic versions from being manufactured in the United States.
When Will a Generic Version Be Available?The first patent for Edarbyclor is set to expire in June 2012. This is the earliest predictable date that a generic version could become available.
However, other circumstances could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for new Edarbyclor uses. Once the drug goes off-patent, there may be several companies that manufacture a generic Edarbyclor drug.
Is It Cheaper to Take Azilsartan and Chlorthalidone Separately?In general, it is unlikely that taking the two components separately would result in significant savings. Azilsartan is not available in generic form and is usually priced about the same as Edarbyclor; plus, you would have the additional cost of a separate chlorthalidone prescription.
If you are having trouble paying for Edarbyclor, talk with your healthcare provider or pharmacist about ways to afford your medications. You may qualify for special assistance; if not, your healthcare provider may recommend that you switch to a more affordable medication.